InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the ...
Selection Follows Positive Phase 3 Results for Paridiprubart Demonstrating Statistically Significant Mortality Reductions in ...
Giant kelp forests once defined much of San Diego’s coastline: towering marine canopies that shelter fish populations, buffer ...
The next frontier for economic emancipation By Ing. Prof. Douglas Boateng There is an uncomfortable truth that echoes quietly ...
Preview this article 1 min Biogen is buying a Boston-area biotech that already has two approved drugs to drive short-term and ...
CALGARY, AB, March 31, 2026 /CNW/ - Genome Alberta, with support from the Government of Alberta, is pleased to announce five ...
Dr. Christina Rahm, a recognized leader in science and innovation, has been selected as one of "MSN's Top 10 Trailblazing Women in 2026," a ...
CollectiveMinds LLC, a leading next-generation executive search firm specializing in life sciences and biotechnology, today announced the successful placement of Robert Hollingsworth, PhD, as Chief ...
The six companies that have priced initial public offerings so far banked a median of $287.5 million, a figure far surpassing ...
This article examines the rise and fall of Allbirds, from its 2016 launch and 4 billion dollar valuation to its recent sale ...
Opinion
Pharmaceutical Technology on MSNOpinion

Navigating commercial gaps to supercharge the UK life sciences sector

For the UK to fully harness its potential in the global life sciences market, commercial, funding and systemic challenges must be tackled.
Chemicals company Evonik is realigning its strategic research unit. The Evonik Innovation Factory operates as an ...